META-ANALYSIS ON THE EFFICACY AND SAFETY OF NEW ORAL ANTICOAGULANTS COMPARED WITH VITAMIN K ANTAGONISTS IN PATIENTS UNDERGOING CARDIOVERSION FOR ATRIAL FIBRILLATION

被引：0
|
作者：
Turagam, Mohit [1 ]
Velagapudi, Poonam [1 ]
Vuddanda, Venkat [1 ]
Lavu, Madhav [1 ]
Jazayeri, Mohammad-Ali [1 ]
Parikh, Valay [1 ]
Tarun, Tushar [1 ]
Atkins, Donita [1 ]
Aggarwal, Kul [1 ]
Bommana, Sudharani [1 ]
Di Biase, Luigi [1 ]
Natale, Andrea [1 ]
Reddy, Madhu [1 ]
Lakkireddy, Dhanunjaya [1 ]
机构：
[1] Univ Kansas Hosp, Kansas City, KS USA
来源：
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY | 2017年 / 69卷 / 11期
关键词：
D O I：
10.1016/S0735-1097(17)33836-6
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
1189-094
引用
收藏
页码：447 / 447
页数：1
相关论文
共 50 条
  • [41] Efficacy and safety of oral anticoagulants in atrial fibrillation patients with cancer—a network meta-analysis
    Pingping Yang
    Dan Zhu
    Xiuxiu Xu
    Wen Shen
    Chenxi Wang
    Yu Jiang
    Gaosi Xu
    Qinghua Wu
    Heart Failure Reviews, 2020, 25 : 823 - 831
  • [42] Direct oral anticoagulants versus vitamin k antagonists in patients with atrial fibrillation and bioprosthesis: a systematic review and meta-analysis
    Guardia Martinez, P.
    Aviles Toscano, A. L.
    Martinez Mayoral, M. A.
    Molto Miralles, J.
    EUROPEAN HEART JOURNAL, 2023, 44
  • [43] Direct Oral Anticoagulants vs. Vitamin K Antagonists in Atrial Fibrillation Patients at Risk of Falling: A Meta-Analysis
    Gao, Xinxing
    Huang, Donghua
    Hu, Yuting
    Chen, Yuanyuan
    Zhang, Haidong
    Liu, Fuwei
    Luo, Jun
    FRONTIERS IN CARDIOVASCULAR MEDICINE, 2022, 9
  • [44] Non-vitamin K antagonist oral anticoagulants in atrial fibrillation patients undergoing elective cardioversion
    Itainen, Saga
    Lehto, Mika
    Vasankari, Tuija
    Mustonen, Pirjo
    Kotamaki, Mervi
    Numminen, Anna
    Lahtela, Heli
    Bah, Aissa
    Hartikainen, Juha
    Hekkala, Anna-Mari
    Airaksinen, Juhani K. E.
    EUROPACE, 2018, 20 (04): : 565 - 568
  • [45] Comment on "Non-vitamin K antagonists oral anticoagulants are as safe and effective as warfarin for cardioversion of atrial fibrillation: A systematic review and meta-analysis"
    Jenabi, Ensiyeh
    INTERNATIONAL JOURNAL OF CARDIOLOGY, 2019, 277 : 139 - 139
  • [46] Superiority of Direct Oral Anticoagulants over Vitamin K Antagonists in Oncological Patients with Atrial Fibrillation: Analysis of Efficacy and Safety Outcomes
    Parrini, Iris
    Luca, Fabiana
    Rao, Carmelo Massimiliano
    Parise, Gianmarco
    Micali, Linda Renata
    Musumeci, Giuseppe
    La Meir, Mark
    Colivicchi, Furio
    Gulizia, Michele Massimo
    Gelsomino, Sandro
    JOURNAL OF CLINICAL MEDICINE, 2022, 11 (19)
  • [47] Meta-analysis of the efficacy and safety of non-vitamin K antagonist oral anticoagulants with warfarin in Latin American patients with atrial fibrillation
    Su, Zhiyu
    Zhang, Hao
    He, Wenfeng
    Ma, Jianyong
    Zeng, Junquan
    Jiang, Xinhua
    MEDICINE, 2020, 99 (18) : E19542
  • [48] The efficacy and safety of direct oral anticoagulants compared with vitamin K antagonist in patients with hypertrophic cardiomyopathy and atrial fibrillation
    Lyu, Si-qi
    Zhu, Jun
    Wang, Juan
    Wu, Shuang
    Zhang, Han
    Shao, Xing-hui
    Yang, Yan-min
    THROMBOSIS JOURNAL, 2024, 22 (01)
  • [49] Vitamin K Antagonists Versus Novel Oral Anticoagulants for Elective Electrical Cardioversion of Atrial Fibrillation
    Tint, Diana
    Petris, Antoniu O.
    Pop, Ioana
    Melnic, Rimma
    Ignat, Andreea-Mihaela
    Rogozea, Liliana M.
    AMERICAN JOURNAL OF THERAPEUTICS, 2017, 24 (05) : E553 - E558
  • [50] The safety and efficacy of nonvitamin K antagonist oral anticoagulants in morbidly obese patients with atrial fibrillation: a meta-analysis
    Sohil Elfar
    Somaya Abdulbaset Mahmoud
    Samar Hamdi
    Aya Ahmed Emad
    Mohamed Abd-ElGawad
    Nouran A. Taha
    BMC Cardiovascular Disorders, 24
12345